Aristotle Capital Boston, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1633911
BOSTON, MA
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,273,377
+$1,466,012 QoQ
Shares Held
80,574
-17.3% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#82
of 570 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aristotle Capital Boston, LLC holds $18,273,377 across 1 Diagnostics & Research name. CRL ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
This page
|
80,574 | $18,273,377 |
All Filings in CRL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,273,377 | 80,574 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,807,365 | 97,434 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,197,968 | 86,214 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,918,148 | 95,348 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,619,337 | 96,351 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,726,329 | 104,480 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,027,720 | 130,161 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,503,725 | 144,711 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,130,366 | 150,694 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,257,480 | 148,579 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $36,328,060 | 153,672 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,142,005 | 158,904 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $33,708,121 | 160,324 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,631,248 | 156,730 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $33,514,109 | 153,805 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $31,125,494 | 158,158 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $37,169,370 | 173,713 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $49,098,129 | 172,899 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,207,781 | 175,720 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $91,894,593 | 222,683 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $108,692,483 | 293,827 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $94,392,414 | 325,682 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $88,893,191 | 355,772 | Shares | Sole | 2021-02-22 | |
| 2020-09-30 | $91,786,299 | 405,327 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $68,873,480 | 395,030 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $45,442,162 | 360,052 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||